Douglas Abel, President and CEO at MANHATTAN PHARMACEUTICALS INC (MHA), bought 5,000 shares at $0.75 ($4K) on 2006-07-10, disclosed to the SEC on 2006-07-10.
Open-market purchase of $4k MHA by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.